Morgan Stanley’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-86,573
| Closed | -$992K | – | 7709 |
|
2020
Q4 | $992K | Buy |
86,573
+82,308
| +1,930% | +$943K | ﹤0.01% | 4673 |
|
2020
Q3 | $30K | Sell |
4,265
-122,551
| -97% | -$862K | ﹤0.01% | 5913 |
|
2020
Q2 | $827K | Buy |
126,816
+113,033
| +820% | +$737K | ﹤0.01% | 4310 |
|
2020
Q1 | $91K | Sell |
13,783
-58,000
| -81% | -$383K | ﹤0.01% | 5225 |
|
2019
Q4 | $744K | Buy |
71,783
+60,828
| +555% | +$630K | ﹤0.01% | 4710 |
|
2019
Q3 | $69K | Buy |
10,955
+5,023
| +85% | +$31.6K | ﹤0.01% | 5580 |
|
2019
Q2 | $44K | Buy |
5,932
+2,412
| +69% | +$17.9K | ﹤0.01% | 5667 |
|
2019
Q1 | $22K | Sell |
3,520
-18,831
| -84% | -$118K | ﹤0.01% | 5986 |
|
2018
Q4 | $257K | Sell |
22,351
-1,518
| -6% | -$17.5K | ﹤0.01% | 5182 |
|
2018
Q3 | $516K | Sell |
23,869
-41,069
| -63% | -$888K | ﹤0.01% | 4983 |
|
2018
Q2 | $1.02M | Buy |
64,938
+41,074
| +172% | +$648K | ﹤0.01% | 4621 |
|
2018
Q1 | $450K | Buy |
23,864
+1,720
| +8% | +$32.4K | ﹤0.01% | 5067 |
|
2017
Q4 | $385K | Sell |
22,144
-19,601
| -47% | -$341K | ﹤0.01% | 5112 |
|
2017
Q3 | $625K | Buy |
41,745
+11,841
| +40% | +$177K | ﹤0.01% | 4735 |
|
2017
Q2 | $555K | Sell |
29,904
-10,401
| -26% | -$193K | ﹤0.01% | 4734 |
|
2017
Q1 | $681K | Buy |
40,305
+5,968
| +17% | +$101K | ﹤0.01% | 4650 |
|
2016
Q4 | $731K | Buy |
34,337
+31,579
| +1,145% | +$672K | ﹤0.01% | 4682 |
|
2016
Q3 | $50K | Sell |
2,758
-23,360
| -89% | -$423K | ﹤0.01% | 5596 |
|
2016
Q2 | $756K | Buy |
+26,118
| New | +$756K | ﹤0.01% | 4177 |
|